Partner
Kate Hillier’s practice focuses on the representation of public and private life sciences companies discovering, developing and marketing biopharmaceutical, vaccine, medical device, diagnostic and digital health products.
Kate counsels clients in relation to transactions involving complex intellectual property, business, operational and legal issues, with the aim of maximizing the value of her clients’ products and technology. She works closely with her clients in connection with their overall licensing and partnering strategy and in structuring and negotiating critical transactions. In addition, she counsels clients on matters involving foundational in-licenses and complex commercial arrangements. Kate has been ranked as a top practitioner by Chambers USA in Life Sciences: Corporate and Commercial since 2022, and as a Next Generation Partner in Healthcare and Life Sciences by The Legal 500 since 2020.